[go: up one dir, main page]

Pattabiraman, 2004 - Google Patents

The design, synthesis and evaluation of guanidine-based molecular transporters

Pattabiraman, 2004

Document ID
8697542000435681113
Author
Pattabiraman K
Publication year

External Links

Snippet

The physical properties of many drugs and drug candidates prevent them from reaching their target in the body and therefore limit their clinical application. Biological barriers in the body such as the cell membrane pose a significant challenge for the delivery of therapeutics …
Continue reading at search.proquest.com (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48238—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being a protein, peptide, polyamino acid
    • A61K47/48246—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being a protein, peptide, polyamino acid drug-peptide, protein or polyamino acid conjugates, i.e. the modifying agent being a protein, peptide, polyamino acid which being linked/complexed to a molecule that being the pharmacologically or therapeutically active agent
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral

Similar Documents

Publication Publication Date Title
El-Andaloussi et al. Cell-penetrating peptides: mechanisms and applications
Fischer Cellular uptake mechanisms and potential therapeutic utility of peptidic cell delivery vectors: progress 2001–2006
Deshayes et al. Cell-penetrating peptides: tools for intracellular delivery of therapeutics
Pujals et al. Proline-rich, amphipathic cell-penetrating peptides
Gupta et al. Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides
Nakase et al. Methodological and cellular aspects that govern the internalization mechanisms of arginine-rich cell-penetrating peptides
Patel et al. Cell penetrating peptides: intracellular pathways and pharmaceutical perspectives
Futaki Membrane-permeable arginine-rich peptides and the translocation mechanisms
Järver et al. Cell-penetrating peptides—a brief introduction
Jones et al. Cell entry of cell penetrating peptides: tales of tails wagging dogs
Martin et al. Peptide-guided gene delivery
Letoha et al. Membrane translocation of penetratin and its derivatives in different cell lines
Pooga et al. Classes of cell-penetrating peptides
US6376248B1 (en) Peptide-enhanced transfections
CA2632451C (en) Cell penetrating peptides for intracellular delivery of molecules
Zaro et al. Cationic and amphipathic cell-penetrating peptides (CPPs): Their structures and in vivo studies in drug delivery
US8058068B2 (en) Peptide-enhanced transfections
Deshayes et al. Structural polymorphism of non-covalent peptide-based delivery systems: highway to cellular uptake
US20060222657A1 (en) Polypeptide transduction and fusogenic peptides
EP2784081B1 (en) Development of novel macromolecule transduction domain with improved cell permeability and method for using same
Zorko et al. Cell-penetrating peptides
WO2014053882A1 (en) Cell penetrating peptides for intracellular delivery of molecules
Hudecz et al. Medium‐sized peptides as built in carriers for biologically active compounds
Oba et al. Cell-penetrating peptides: design, development and applications
Pattabiraman The design, synthesis and evaluation of guanidine-based molecular transporters